AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... [Yahoo! Finance]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Yahoo! Finance
Med Device Revenue: $40.4 million, a 2.3% increase. Auryon Revenue: $16.5 million, growing 20.1% year-over-year. Mechanical Thrombectomy Revenue: $11.3 million, a 41.2% increase. AngioVac Revenue: $8 million, a 37.1% increase. AlphaVac Revenue: $3.3 million, a 52.3% increase. NanoKnife Revenue: $6.4 million, a 26.7% increase. Gross Margin: 55.3%, a 90 basis point increase from the previous year. Adjusted Net Loss: $4.2 million or $0.10 per share. Adjusted EBITDA: $2.2 million, compared to a loss of $152,000 in the previous year. Cash Position: $38.8 million as of August 31, 2025. Fiscal 2026 Revenue Guidance: Raised to $308 million to $313 million. Med Tech Sales Growth Guidance: 14% to 16%. Adjusted Loss Per Share Guidance: Improved to a range of $0.33 to $0.23. Warning! GuruFocus has detected 5 Warning Signs with ANGO. Is ANGO fairly valued? Test your thesis with our free DCF calculator. Release Date: October 02, 2025 For the complete transcript of t
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]Seeking Alpha
- AngioDynamics to Participate in the UBS Global Healthcare ConferenceBusiness Wire
- H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance [Yahoo! Finance]Yahoo! Finance
- Insider Spends US$112k Buying More Shares In AngioDynamics [Yahoo! Finance]Yahoo! Finance
- AngioDynamics' NanoKnife® System Named to TIME's 2025 Best Inventions List [Yahoo! Finance]Yahoo! Finance
ANGO
Earnings
- 10/2/25 - Beat
ANGO
Analyst Actions
- 10/3/25 - Canaccord Genuity
ANGO
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- 10/22/25 - Form 4
- ANGO's page on the SEC website